Advertisement
Singapore markets closed
  • Straits Times Index

    3,296.89
    +4.20 (+0.13%)
     
  • S&P 500

    5,018.39
    -17.30 (-0.34%)
     
  • Dow

    37,903.29
    +87.37 (+0.23%)
     
  • Nasdaq

    15,605.48
    -52.34 (-0.33%)
     
  • Bitcoin USD

    58,135.80
    +393.26 (+0.68%)
     
  • CMC Crypto 200

    1,249.92
    -20.82 (-1.64%)
     
  • FTSE 100

    8,151.45
    +30.21 (+0.37%)
     
  • Gold

    2,307.00
    -4.00 (-0.17%)
     
  • Crude Oil

    79.48
    +0.48 (+0.61%)
     
  • 10-Yr Bond

    4.5950
    -0.0910 (-1.94%)
     
  • Nikkei

    38,236.07
    -37.98 (-0.10%)
     
  • Hang Seng

    18,207.13
    +444.10 (+2.50%)
     
  • FTSE Bursa Malaysia

    1,580.30
    +4.33 (+0.27%)
     
  • Jakarta Composite Index

    7,117.42
    -116.77 (-1.61%)
     
  • PSE Index

    6,646.55
    -53.94 (-0.81%)
     

Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1

VAUGHAN, Ontario, April 15, 2024--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter 2024 financial results on Wednesday, May 1, 2024. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of the call.

Conference Call Details

Date:

 

Wednesday, May 1, 2024

 

Time:

 

8 a.m. ET

 

Webcast:

 

https://www.webcaster4.com/Webcast/Page/2883/49631

 

Participant Event Dial-in:

 

+1 (888) 506-0062 (North America)

+1 (973) 528-0011 (International)

 

Participant Access Code:

 

357966

 

Replay Dial-in:

 

+1 (877) 481-4010 (North America)

+1 (919) 882-2331 (International)

 

Replay Passcode:

 

49631 (replay available until May 15, 2024)

About Bausch + Lomb

Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on X, LinkedIn, Facebook and Instagram.

ADVERTISEMENT

© 2024 Bausch + Lomb.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240415028295/en/

Contacts

Media Contact:
T.J. Crawford
tj.crawford@bausch.com
(908) 705-2851

Investor Contact:
George Gadkowski
george.gadkowski@bausch.com
(877) 354-3705 (toll free)